The U.S. Preventive Services Task Force today recommended clinicians offer pre-exposure prophylaxis (PrEP), a pill that helps prevent the spread of HIV, to high-risk patients. High-risk behaviors include having a sex partner with HIV, having sex without a condom with a partner at high risk for HIV and sharing needles or other equipment while injecting drugs, the panel said. PrEP is highly effective at preventing HIV if taken daily, but people who take the pill should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections, the task force said. It also continued to recommend that clinicians screen for HIV in pregnant women, everyone aged 15 to 65, and others at increased risk for HIV. The panel assigned an “A" grade to the recommendations, meaning all copays and deductibles would be waived under the Affordable Care Act.

Related News Articles

Perspective
Even with all the wrenches that have been thrown at it, the ACA has improved access to care, especially among those who needed it most.
Headline
The Centers for Disease Control and Prevention yesterday reported 1,001 cases of measles so far this year, according to the Department of Health and Human…
Headline
Overall cancer death rates continue to decline for U.S. men, women and children, according to the latest Annual Report to the Nation on the Status of Cancer.
Headline
After increasing for almost two decades, the annual number of new diabetes cases in U.S. adults fell by 35 percent between 2008 and 2017, to 1.3 million.
Headline
The Fifth Circuit Court of Appeals said today that it will hear oral arguments July 9 in the appeal of a district court decision that struck down t
Headline
he House of Representatives last night voted 234-183 to pass legislation (H.R. 987) that combines several AHA-supported bills to help lower prescription drug…